Stocks and Investing Stocks and Investing
Wed, May 10, 2023

Matthew Caufield Reiterated (UBX) at Strong Buy and Held Target at $10 on, May 10th, 2023


Published on 2024-10-28 03:37:56 - WOPRAI, Matthew Caufield
  Print publication without navigation


Matthew Caufield of HC Wainwright & Co., Reiterated "Unity Biotechnology, Inc." (UBX) at Strong Buy and Held Target at $10 on, May 10th, 2023.

Matthew has made no other calls on UBX in the last 4 months.



There are 4 other peers that have a rating on UBX. Out of the 4 peers that are also analyzing UBX, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Matthew


  • Andreas Argyrides of "Wedbush" Maintained at Buy with Decreased Target to $3 on, Tuesday, April 25th, 2023
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $6 on, Tuesday, March 28th, 2023
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $5 on, Tuesday, March 28th, 2023
  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $10 on, Thursday, March 16th, 2023

Contributing Sources